How to interpret differing cerebral blood flow patterns estimated with 99tcm-hmpao and 99tcm-ecd spet in a healthy population

Nuclear Medicine Communications

Volumn 20, Issue 3, 1999, Pages 219-226

  Siennicki Lantz, Arkadiusz ^a   ElmstAHl S ^a   Lilja, B ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE ETHYL ESTER TC 99M; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; BRAIN SCINTISCANNING; FEMALE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0032909737     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199903000-00004     Document Type: Article

References (26)

1. Yonekura Y, Ishizu K, Okazawa H Simplified quantification of regional cerebral blood flow with 99mTc-ECD SPECT and continuous arterial blood sampling. Ann Nucl Med 1996; 10: 177-183.
2. Walovitch RC, Hill TC, Garrity ST et al. Characterization of technetium-99m, l, l-ECD for brain perfusion imaging, Part 1: Pharmacology of technetium-99m in nonhuman primates. J Nucl Med 1989; 30: 1892-1901.
3. Ishizu K, Yonekura Y, Magata Y et al. Extraction and retention of technetium-99m-ECD in human brain: Dynamic SPECT and oxygen-15-water PET studies. J Nucl Med 1996; 37: 1600-1604.
4. Walovitch RC, Cheesman EH, Maheu LJ, Hall KM. Studies of the retention mechanism of the brain perfusion imaging agent 99mTc-bicisate (99mTc-ECD). J Cereb Blood Flow Metab 1994; 14(1): S4-S11.
5. Knudsen GM, Andersen AR, Somnier FE, Videbaeck Ch, Hasselbalch S, Paulson OB. Brain extraction and distribution of 99mTc-bicisate in humans and in rats. J Cereb Blood Flow Metab 1994; 14(1): S12-S19.
6. Leveille J, Demonceau G, Walovitch RC. Intrasubject comparison between technetium-99m-ECD and technetium-99m-HMPAO in healthy human subjects. J Nucl Med 1991; 33: 480-484.
7. Huglo D, Rousseaux M, Leys D, Fialdes P, Steinling M. Regional cerebral blood flow imaging: A quantitative comparison of 99mTc-bicisate with 133Xe using single photon emission computed tomography. J Cereb Blood Flow Metab 1994; 14(1): S76-S83.
8. Ogasawara K, Fujiwara S, Yoshimoto T. 99mTc-ECD dynamic SPECT in ’luxury perfusion’ of subacute stroke. Kaku Igaku 1995; 32: 1241-1247.
9. Shishido F, Uemura K, Inugami A et al. Discrepant 99mTc-ECD images of CBF in patients with subacute cerebral infarction: A comparison of CBF, CMR02 and 99mTc-HMPAO imaging. Ann Nucl Med 1995; 9: 6-16.
10. Shuke N, Saito K, Moromoto M et al. Brain perfusion SPECT in neuro-Behcet’s disease: Discordance between Tc-99m-HMPAO and Tc-99m-ECD. Ann Nucl Med 1996; 10: 353-356.
11. Van Dyck CH, Lin CH, Smith EO et al. Comparison of tech-netium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer’s disease. J Nucl Med 1996; 37: 1749-1755.
12. Matsuda H, Yagishita A, Tsuji S, Hisada K. A quantitative approach to technetium-99m ethyl cysteinate dimer: A comparison with technetium-99m hexamethylpropylene amine oxime. Eur J Nucl Med 1995; 27: 633-637.
13. Pupi A, Castagnoli A, De Cristofaro MT, Bacciottini L, Petti AR. Quantitative comparison between 99mTc-HMPAO and 99mTc-ECD: Measurement of arterial input and brain retention. Eur J Nucl Med 1994; 21: 124-130.
14. Koyama M, Kawashima R, Ito H et al. SPECT imaging of normal subjects with technetium-99m-HMPAO and tech-netium-99m-ECD. J Nucl Med 1997; 38: 587-592.
15. Crook TH, Larrabee Gp Interrelationship among everyday memory tests: Stability of a factor structure with age. Neuropsychology 1988; 2: 1-12.
16. Chang LT. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978; 25: 638-643.
17. Yonekura Y, Tsuchida T, Sadato N et al. Brain perfusion SPECT with 99mTc-bicisate: Comparison with PET measurement and linearisation based on permeability-surface area product model. J Cereb Blood Flow Metab 1994; 14(1): S58-S65.
18. Ichise M, Golan H, Ballinger JR, Vines D, Blackman A, Maldofsky H. Regional differences in technetium-99m-ECD clearance on brain SPECT in healthy subjects. J Nucl Med 1997; 38: 1253-1260.
19. Grunwald F, Menzel C, Pavics L et al. Ictal and interictal brain SPECT imaging in epilepsy using technetium-99m-ECD. J Nucl Med 1994; 35: 1896-1901.
20. Walovitch RC, Franceschi M, Picard M Metabolism of 99mTc-L, L-ethyl cysteinate dimer in healthy volunteers. Neuropharmacology 1991; 30: 283-292.
21. Shishido F, Uemura K, Murakami M Cerebral uptake of 99mTc-bicisate in patients with cerebrovascular disease in comparison with CBF and CMR02 measurement by positron emission tomography. J Cereb Blood Flow Metab 1994; 14(1): S66-S75.
22. Nakano S, Matsuda H, Uno M. Regional cerebral blood flow measurements using 99mTc-ECD SPECT in patients with Alzheimer’s disease in the early stage. Kaku Igaku 1996; 33: 1197-1206.
23. Bartenstein P, Minoshima S, Hirsch C et al. Quantitative assessment of cerebral blood flow in patients with Alzheimer’s disease by SPECT. J Nucl Med 1997; 38: 1095-1101.
24. Matsumura K, Watanabe Y, Aoki S et al. Evaluation of regional cerebral blood flow in hippocampus by 99mTc-ECD SPECT: Comparison with 1231-IMP SPECT. Kaku Igaku 1996; 33: 1021-1026.
25. Oku N, Matsumoto M, Hashikawa Ket al. Intra-individual differences between technetium-99m-HMPAO and techne-tium-99m-ECD in the normal medial temporal lobe. J Nucl Med 1997; 38: 1109-1111.
26. Jerntorp P, Berglund G. Stroke registry in Malmö, Sweden. Stroke 1992; 23: 357-361.